Skip to content

An exploratory study on screening lung microbiota in patients with interstitial lung disease by high-throughput sequencing technology

An exploratory study on screening lung microbiota in patients with interstitial lung disease by high-throughput sequencing technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200067075
Enrollment
Unknown
Registered
2022-12-26
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial lung disease(ILD)

Interventions

ILD stable phase:/
advanced ILD :/

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-70; 2. Patients diagnosed as ILD by clinicians based on comprehensive clinical manifestations; 3. Chest high-resolution CT showed grid and honeycomb shadows (ILD stable phase); 4. In addition to typical grid and honeycomb shadows, there were ground-glass or consolidation shadows in both lungs on high-resolution chest CT (advanced ILD). 5. The patient was willing and able to tolerate tracheoscopy.

Exclusion criteria

Exclusion criteria: 1. Patients and/or family members are reluctant to further study for fear of adverse reactions after the inclusion of patients in the study; 2. Have other serious lung diseases such as asthma, bronchiectasis, lung tumors, tuberculosis, etc.; 3. Patients with severe heart, brain, liver, kidney, vascular diseases, malignant tumors, and blood system diseases (excluding cor pulmonale); 4. The diagnosis of ILD was not supported during subsequent diagnosis and treatment.

Design outcomes

Primary

MeasureTime frame
Flora species;

Countries

China

Contacts

Public ContactQin Hongran

Shanghai Pulmonary Hospital

hongranqin@163.com13585614279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026